Wren Laboratories logo — Unleashing the Power of mRNA and AI for Cancer Diagnostics

Wren Laboratories

Unleashing the Power of mRNA and AI for Cancer Diagnostics

Founded 2013 United States Branford, United States 25 employees Biotechnology, Health Care +1

General Information

Company Name Wren Laboratories
Founded Year 2013
Location United States Branford, United States +1
Employees 25
Industries Biotechnology, Health Care, Health and Wellness
Social

Get notified when Wren Laboratories moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Wren Laboratories

Wren Laboratories is revolutionizing cancer diagnostics with advanced machine learning and liquid biopsy mRNA-based technology. Our goal is to provide precise, non-invasive diagnostics tailored to each patient's unique molecular profile, transforming early detection and surveillance of cancer for better patient outcomes. With over 100 patents and validation from more than 60 clinical studies, Wren has developed highly sensitive liquid biopsy mRNA gene expression-based assays. These innovative assays aid in cancer diagnosis, detect minimal residual disease (MRD), and predict tumor prognosis and therapeutic response. Our tests, including the NETest for neuroendocrine tumors and PROSTest for prostate cancer, leverage mRNA technology and AI/ML genomic assays for unparalleled molecular insights. This allows accurate detection of cancer markers, empowering personalized care. Our mRNA-based diagnostics are crucial in monitoring patients post-surgery or treatment. Wren also offers Biopharma services with AI/ML liquid biopsy genomic assays for research and companion diagnostics (CDx) development. Our RNA stabilizer tubes preserve whole blood at ambient temperature for up to 10 days, reducing clinical trial logistics. From our CLIA-certified, CAP-accredited, and NYS-licensed lab, our tests ensure high accuracy and reliability. For more information, visit our website and follow us for updates in non-invasive cancer diagnostics.

No funding data available for Wren Laboratories yet.

Get notified when Wren Laboratories raises funding

Wren Laboratories Alternatives & Competitors

Wren Laboratories vs
Anchor Molecular
Anchor Molecular United States

Best-in-Class Quality Controls and Reference Materials for Molecular Testing

2 employees
Biotechnology, Health Care
Wren Laboratories vs

Leading developer of NGS technologies, including in cfDNA liquid biopsies for cancer diagnostic. Par...

24 employees
Biotechnology, Health Care
Wren Laboratories vs
Predicine
Predicine United States

Advancing precision medicine through next-generation liquid biopsy oncology platform

89 employees
Biotechnology, Health Care

FAQ About Wren Laboratories

Unleashing the Power of mRNA and AI for Cancer Diagnostics
Wren Laboratories was founded in 2013.
Wren Laboratories is headquartered in Branford, United States.
Wren Laboratories operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Wren Laboratories has approximately 25 employees.
Top alternatives and competitors to Wren Laboratories include Anchor Molecular, Resolution Bioscience, Predicine, PetDx, Surfix. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Wren Laboratories and Anchor Molecular are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Wren Laboratories and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy